Stay updated with breaking news from Petera Kiener. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cue Biopharma, Inc. (NASDAQ:CUE – Get Rating) saw a significant increase in short interest in May. As of May 31st, there was short interest totalling 731,600 shares, an increase of 36.2% from the May 15th total of 537,100 shares. Based on an average trading volume of 243,300 shares, the days-to-cover ratio is currently 3.0 days. […]
Cue Biopharma (NASDAQ:CUE – Get Rating) announced its earnings results on Tuesday. The company reported ($0.29) EPS for the quarter, beating analysts’ consensus estimates of ($0.33) by $0.04, Zacks reports. The business had revenue of $0.19 million during the quarter, compared to analysts’ expectations of $0.30 million. Cue Biopharma had a negative net margin of […]
Cue Biopharma, Inc. (NASDAQ:CUE – Get Rating) was the target of a large drop in short interest during the month of April. As of April 15th, there was short interest totalling 678,200 shares, a drop of 10.5% from the March 31st total of 757,900 shares. Based on an average trading volume of 141,300 shares, the […]
Cue Biopharma, Inc. (NASDAQ:CUE – Get Rating) was the recipient of a large decrease in short interest during the month of April. As of April 15th, there was short interest totalling 678,200 shares, a decrease of 10.5% from the March 31st total of 757,900 shares. Based on an average daily volume of 141,300 shares, the […]
Cue Biopharma, Inc. (NASDAQ:CUE – Get Rating) saw a large drop in short interest in April. As of April 15th, there was short interest totalling 678,200 shares, a drop of 10.5% from the March 31st total of 757,900 shares. Based on an average daily volume of 141,300 shares, the short-interest ratio is currently 4.8 days. […]